Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions

PURPOSE: To examine short-term effects of ranibizumab versus bevacizumab on reduction of optical coherence tomography (OCT) central macular thickness (CMT) in patients with macular edema secondary to retinal vein occlusions (RVOs). METHODS: This is a retrospective analysis in which patients with RVO...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Michael A, Cohen, Steven R, Groth, Sylvia L, Porbandarwalla, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711954/
https://www.ncbi.nlm.nih.gov/pubmed/23874079
http://dx.doi.org/10.2147/OPTH.S46235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711954/
https://www.ncbi.nlm.nih.gov/pubmed/23874079
http://dx.doi.org/10.2147/OPTH.S46235

Ejemplares similares